Find Your Doctor

Doctors

    Dr. Srikant Tiwari

    Senior Consultant, Medical Oncology

    MBBS | MD (Medicine) | DNB (Medical Oncology) | ECMO (European Certified Medical Oncologist)

    About Dr. Srikant Tiwari

    Dr. Srikant Tiwari is a highly experienced Medical Oncologist specializing in the diagnosis and treatment of hematological and non-hematological malignancies. With extensive expertise in chemotherapy, immunotherapy, targeted therapy, and bone marrow transplantation, he provides comprehensive cancer care. He is a European Certified Medical Oncologist and has contributed to numerous national and international research publications. Dr. Tiwari is dedicated to advancing cancer treatment and improving patient outcomes.

    Expertise

    Hematological Malignancies | Non-Hematological Malignancies | Breast Cancer | Lung Cancer | Gastrointestinal Cancer | Gynecological Cancer | Chemotherapy | Immunotherapy | Hormonal Therapy | Targeted Therapy | Bone Marrow Transplantation | Oncological Emergencies Management | Clinical Research | Research Ethics | Patient-Centric Cancer Care & Communication

    Gender

    Male

    Department

    Oncology (Medical and Surgical)

    Practice

    15 Years

    Languages Spoken

    Hindi, English

    Room Number

    F12

    OPD Days

    Mon - Sat

    OPD Timings

    09:30 AM - 5:00 PM

    • Senior Consultant, Medical Oncology – Jawaharlal Nehru Cancer Hospital & Research Centre, Bhopal (2016 – Present)
    • Senior Consultant, Medical Oncology – Bansal Hospital, Bhopal (2015 – 2016)
    • Consultant, Medical Oncology – Rajiv Gandhi Cancer Hospital & Research Center, Delhi (2015)
    • DNB Resident, Medical Oncology – RGCI & RC, New Delhi (2012 – 2015)

    • European Certified Medical Oncologist – Certification by the European Society for Medical Oncology (ESMO)
    • Multiple Research Publications in National and International Peer-Reviewed Journals
    • Presented Research Papers at Various National and International Oncology Conferences
    • Active Member of Prestigious Oncology Societies, including ESMO, ICON, and ISMPO

    • European Society of Medical Oncology (ESMO)
    • Indian Society of Medical & Pediatric Oncology (ISMPO)
    • Indian Cooperative Oncology Network (ICON)
    • Indian Medical Association (IMA)

    • Non-Small-Cell Lung Carcinoma Presenting as a Foot SwellingLung India: Official Organ of Indian Chest Society (Accepted for publication)
    • Efficacy and Toxicity of FOLFOX-4 as Second-Line Chemotherapy in Gallbladder CancerJ Clin Oncol 32, 2014 (suppl; abstr e15101)
    • Efficacy & Safety Profile of Gemcitabine & Erlotinib in Advanced Pancreatic CancerIndian J Cancer, 2013 (Suppl:S121, abstract id: 1369)
    • Triple Negative Breast Cancer: Clinical and Pathological Profile of Basal & Non-Basal SubtypesIndian J Cancer, 2013 (Suppl:S30, abstract id: 1239)
    • Efficacy and Toxicity of Cetuximab with Chemotherapy in Recurrent and Metastatic Head and Neck CancerProspective Observational Study

    • Non-Small-Cell Lung Carcinoma Presenting as a Foot SwellingLung India: Official Organ of Indian Chest Society (Accepted for publication)
    • Efficacy and Toxicity of FOLFOX-4 as Second-Line Chemotherapy in Gallbladder CancerJ Clin Oncol 32, 2014 (suppl; abstr e15101)
    • Efficacy & Safety Profile of Gemcitabine & Erlotinib in Advanced Pancreatic CancerIndian J Cancer, 2013 (Suppl:S121, abstract id: 1369)
    • Triple Negative Breast Cancer: Clinical and Pathological Profile of Basal & Non-Basal SubtypesIndian J Cancer, 2013 (Suppl:S30, abstract id: 1239)
    • Efficacy and Toxicity of Cetuximab with Chemotherapy in Recurrent and Metastatic Head and Neck CancerProspective Observational Study
    • Study of Efficacy and Toxicity Profile of Gemcitabine and Erlotinib in Locally Advanced & Metastatic Pancreatic CancerPancreatology, Vol. 16, Issue 1, S9
    • Neo-Adjuvant Chemotherapy Followed by Radical Surgery in Stage IB2 - IIIA Cervical CancerIndian J Cancer, 2013 (Suppl:S110, abstract id: 1596)